Most Recent Buy
1,037
Last traded 1h ago
Most Recent Sell
1,521
Last traded 59m ago
07Flip Buy
07Flip Sell
Antidote+(4) is a members item tradeable on the Old School RuneScape Grand Exchange: 4 doses of extra strong antipoison potion. It currently sells (instant) for 1,521 GP and buys for 1,037 GP. After the 2% GE tax that is a 484 GP margin and 454 GP profit per item (43.8% ROI), with a confidence score of 38/100. Its buy limit of 4,000 every 4 hours allows up to 1,816,000 GP profit per full cycle. Roughly 124,453 units have traded over the past 7 days. Over the last 30 days it has traded between 456 and 2,135 GP, and the current price is 16.1% below its 7-day average. High alchemy returns 216 GP — below its current buy price, so flipping is more profitable than alching. Prices update every minute from the OSRS Wiki Real-Time Prices API.
The chart above shows Antidote+(4)'s price history with RSI, MACD, EMA, and Fibonacci retracement indicators to help identify trends before placing Grand Exchange offers.
Browse all items: items starting with A · full A–Z directory
Antidote+(4) currently sells for 1,521 GP and buys for 1,037 GP on the OSRS Grand Exchange. 07Flip refreshes this price every minute from the OSRS Wiki Real-Time Prices API.
The Grand Exchange buy limit for Antidote+(4) is 4,000 every 4 hours. At the current 454 GP profit per item, one full buy-limit cycle is worth up to 1,816,000 GP.
Flipping Antidote+(4) currently returns about 454 GP per item after the 2% GE tax, from a 484 GP pre-tax margin (43.78% ROI). 07Flip's confidence score for this flip is 38/100, with roughly 124,453 units traded in the last 7 days.
Over the past 30 days Antidote+(4) has traded between 456 and 2,135 GP on the Grand Exchange, averaging 1,779 GP. The current sell price is 16.1% below its 7-day average.
High Level Alchemy converts Antidote+(4) into 216 GP, 821 GP below its current 1,037 GP buy price, so alching it loses money.
Yes. Antidote+(4) is a members item, so it can only be bought, sold and used on a membership account.
